Why Dermira Stock Jumped Again Today

Shares of Dermira (NASDAQ: DERM) jumped 10.5% higher as of 2:35 p.m. EDT on Tuesday. The nice gain came after Citi analyst Liav Abraham bumped the one-year price target for Dermira to $20 from $15. Abraham's increased optimism stemmed from Dermira's announcement on Monday of positive phase 2b results for lead candidate lebrikizumab in treating atopic dermatitis.